SEC Form 4 · accession 0001179110-18-009810

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer

Period of report

Jul 16, 2018

Accepted (ET)

Jul 18, 2018 · 4:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jul 16, 2018	M	7,353	—	A	7,353	D
Common Stock	Jul 16, 2018	M	15,415	$35.45	A	22,768	D
Common Stock^F2,F3	Jul 16, 2018	S	7,353	$65.87	D	15,415	D
Common Stock^F2,F3	Jul 16, 2018	S	15,415	$65.72	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F5,F6	—	Jul 16, 2018	M	7,353	D	—	—	Common Stock	7,353	22,059	D
Employee Stock Option (right to buy)^F4	$35.45	Jul 16, 2018	M	15,415	D	—	Jul 14, 2027	Common Stock	15,415	46,245	D

F1Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 14, 2018.
F3Represents the weighted average price of transactions ranging from $65.50 to $66.20. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
F5Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F6The restricted stock unit vests in four equal annual installments beginning July 14, 2018.